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High thermal stability, pH responsive organogels of 2H-
benzo[d]1,2,3-triazole derivatives as pharmaceutical crystallization 
media 
Iván Torres-Moyaa,b, Basanta Saikiac, Pilar Prietob*, José R. Carrillob and Jonathan W. Steeda* 
2H-benzo[d]1,2,3-triazole derivatives with a range of chemical functionalities showed significant organogel formation, 
particularly bis-amide derivative 4e which gave robust thermally stable gels, in a range of solvents down to 0.1 wt%. The 
gelators proved responsive under pH stimuli or to the presence of metal cations. The gels also proved to be useful vehicles 
to crystallize pharmaceutical drugs, resulting in a change in polymorphic outcome in the case of sulfathiazole compared to 
the solution crystallization outcome.  
Introduction 
For many years, gels have been considered as being materials that 
are “easier to recognize than define”, a statement dating to 1926 by 
Lloyd.1 The contemporary picture of molecular gels2 is a semi-solid 
material composed of low concentrations (<15% by mass) of gelator 
molecules that, in the presence of a particular solvent, self-
assemble physically through intermolecular interactions into an 
extensive network preventing solvent flow as a result of surface 
tension. Organogels are distinguished by their predominantly 
organic continuous phase and can then be further subdivided based 
on the nature of the gelator molecule: polymeric or low molecular 
weight (LMW) organogelators. LMW organogelators usually form 
gels due to the presence of self-assembled fibres arising from inter-
molecular interactions such as hydrogen bonds, van der Waals 
forces and -stacking. The self-assembly of these LMW 
organogelators depends on the evolution of tertiary structure by 
processes such as scrolling, braiding and entanglement3 via physical 
interactions involving aggregates that are sufficiently long-lived to 
give a structure that is permanent on the timescale of an analytical 
experiment.4 
 
Despite the fact that a plethora of LWM organogels have been 
reported and recent work has uncovered some trends in gelation 
tendency,5 it is still difficult to predict the molecular structure of a 
promising gelator and in what solvents a gel may be formed.6 The 
discovery of gelators remains serendipitous and usually involves 
screening of different solvent systems potentially compatible with 
gelation. It is clear that without consideration of the solvent 
properties, the development of new types of molecular gels will be 
challenging. Consideration of specific solvent properties such as 
dipole moment, dielectric constant, refractive index, solvachromic 
shift or Hildebrand solubility parameter, can bring us closer to 
understanding the mechanism of gelation, but this analysis still falls 
short of explicitly predicting gelation behaviour.7 A new method has 
been reported to help predict the behaviour of a known gelator.8 
Based on the previous behaviour of the gelator in a wide range of 
solvents, it is possible to define a solubility sphere and one (or 
more) gelation spheres bearing in mind the Hansen solubility 
parameters.9 If the untested solvent parameters fall in the solubility 
sphere or in the gelation sphere, then this solvent will be able to 
either dissolve the gelator or allow the formation of a gel, 
respectively. While this approach depends on the quality of the 
available solubility data set, it represents a useful tool to reduce the 
number of tests in gelation behaviour studies. However, many 
other factors such as steric effects, rigidity, polarity and aggregation 
rate may affect the aggregation tendency. For this reason, control 
over the gelation process as well as the discovery of new types of 
organogelators remain important challenges. Of particular recent 
interest are gelators that exhibit a response to external stimuli 
leading to switchable gelation behaviour or tunable rheology.10 
Such programmability, however, further complicates the gelation 
landscape. 
One interesting recent application of organogels is as media for the 
crystallization of pharmaceutical compounds. The control of drug 
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solid form and hence properties such as bioavailability and 
dissolution rate is vitally important in the pharmaceutical industry.11 
Polymorphic form, crystal morphology and particle size can highly 
influence a material’s solubility, compressibility, friability, melting 
point, hygroscopy, bulk density and dissolution rate.12,13  
Furthermore, polymorphism control may offer the transformation 
of an amorphous or poorly crystalline active pharmaceutical 
ingredient (API) into a readily handled, stable crystalline solid and 
understanding of the solid form landscape is tremendously 
important in obtaining regulatory approval.14 Because they offer a 
potential alternative nucleation pathway, gels can give rise to novel 
polymorphs and hence modify drug solid state properties. The gel 
environment can also potentially influence crystal habit, particle 
size and enantiomorphism.15,16,17  
There are some recent studies in which triazole and benzoimidazole 
derivatives as organogels have been described.18,19,20 Benzotriazole 
derivatives possess significant potential in a number of 
applications.21 Benzotriazole is a moderate electron acceptor 
moiety which can be easily modified by the introduction of different 
substituents on the nitrogen in the 2-position modulating the 
electron acceptor properties, and the carbon atoms at the 4 and 7 
positions in the benzene-derived ring are very reactive, so it is 
possible to introduce different groups to modulate the chemical 
structure and as a consequence its properties. A convenient 
functionalization of the benzotriazole moiety has afforded 
derivatives with application as optical waveguides,22 organic field-
effect transistors,23 and in bioimaging.24 In this work, we report a 
series of novel 2H-benzo[d]1,2,3-triazole derivatives that function 
as LMW organogelators and the application of their gels as drug 
crystallization media. 
Results and Discussion 
Synthesis 
Benzotriazoles 4 were prepared by the synthetic approach 
described by Höger from 1-nitro-2-nitrosobenzene and 3,5-
bis(trifluoromethyl)aniline.25 Bromination of benzotriazoles 1 
afforded the dibromobenzotriazole 2 in good yield (Scheme 1). A 
double Sonogashira C–C cross-coupling reaction between 
dibromobenzotriazole 2 and arylacetylenes 3 using reusable Pd-
EnCat TPP30, 1,5-diazabicyclo[5.4.0]undecene-5-ene (DBU), CuI and 
microwave irradiation afforded the arylalkynylbenzotriazoles of 
type 4 within 20 minutes in good yields. This sustainable procedure 
for the preparation of triazole and benzotriazole derivatives has 
been widely employed in our research group.22,26 All compounds 
gave satisfactory characterisation data. 
 
 
Scheme 1. Synthesis of the possible gelators 4. 
Derivative 3b was commercially available and was used without 
previous purification. Derivatives 3a, 3c, 3d and 3e were 
synthesized according to literature procedures as described below. 
For the synthesis of the acetylenic derivative 3a, the procedure 
described by Ma et al. was followed.27 The synthesis of the 
derivative takes place by a Sonogashira reaction between the 
halogenated derivative and ethynyltrimethylsilane followed by 
deprotection of the SiMe3 group with K2CO3 in MeOH/THF (Scheme 
S1 in SI). The alkynyl derivative 3c was prepared by N-alkylation of 
4-bromobenzamide28, following by the formation of the triple bond 
and later deprotection with the procedure described for 3a. 
(Scheme S2 in SI). Derivative 3d was prepared by reaction between 
commercially available 4-ethynylaniline, and 3,4,5-
tris(dodecyloxy)benzoic acid following the procedure described by 
Tian.29 (Scheme S3 in SI). Synthesis of derivative 3e proved more 
challenging than the other compounds. First, hydrolysis of methyl 
3,4,5-tris(dodecyloxy)benzoate in basic media gave 3,4,5-
tris(dodecyloxy)benzoic acid30, followed by the formation of the 
acid chloride30 and the amide group by reaction with 
dietyhylenediamine.30 Finally, reaction with 4-
((trimethylsilyl)ethynyl)benzoic acid and deprotection gave the final 
product (Scheme 2). 
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    Scheme 2. Synthesis of the alkynyl derivative 3e. 
Gelation tests 
Gelation tests were carried out for compounds of type 4 using thirty 
different solvents and at different concentrations (2% wt, 1% wt. 
and 0.5% wt). Gelators were dissolved in 0.5 mL of the respective 
solvent through gentle heating followed by sonication for 1 min 
until complete dissolution. The vials were then kept undisturbed at 
room temperature. The vials were checked after 4, 24, 48 and 72 
hours using the simple tube inversion test to assess the flow 
properties of the resulting mixture. Results are collected in Tables 
S1-S15 in the Supporting Information. The outcomes of the gelation 
tests showed that compound 4b did not give gels in any solvent and 
in any concentration. Compound 4c gelled partially at 
concentrations of 2% wt. and 1% wt. in 1,4-butanediol but after 
inversion for 20-30 seconds the gel broke down and began to flow. 
On the other hand, 4a, 4d and 4e gave gels in a range of solvents. 
Compound 4a gave opaque gels in four solvents (1,4-butanediol, 2-
propanol, 1-pentanol and methanol) at a concentration of 2% wt. 
(Figure 1a) and in two solvents (1,4-butanediol and 1-pentanol) at 
1% wt. (Figure S1 in Supporting Information). Compound 4d 
behaved similarly to 4c, giving a partial gel in 1,4-butanediol as well 
as gels in DMF and diethylene glycol (Figure 1b). Finally, 4e proved 
to be a highly effective gelator even at low concentration in a range 
of solvents. For example, gels of 4e at a concentration of 1% wt. are 
shown in Figure 1c. This compound proved to be particularly 
effective at gelling even relatively polar alcohol solvents and its 
gelation ability is likely to be linked to the presence of the 
additional amide group in conjunction with the relative 
hydrophobicity of the molecule resulting in hydrophobically 
insulated, multiple hydrogen bonded stacks of molecules. 
a)                            b)                               c) 
                           
Figure 1. a) Gels of 4a at 2% wt. in (from left to right) 1,4-
butanediol, 2-propanol, 1-pentanol and methanol. b) Gels of 4d at 
2% wt. in (from left to right) DMF and diethylene glycol. c) Gels of 
4e at 1% wt. in (from left to right) in ethanol, methanol, hexane, 2-
butanol, 1-propanol, 1-butanol, 2-propanol and 1,4-butanediol. 
The minimum concentration of gelator needed to give a self-
supporting gel (critical gelation concentration, CGC)31 was assessed 
for the gels identified in the initial screening tests and is given in 
Table 1. 
Table 1. CGC for derivatives 4a, 4d and 4e.  
Compound Entry Solvent 
CGC 
(%wt) 
4a 
 
1 2-propanol 1.6 
2 Methanol 1.7 
3 1-pentanol 0.7 
4 1.4-butanediol 0.8 
4d 
5 DMF 1.8 
6 Diethylene glycol 1.5 
4e 
7 DMF 1.8 
8 Hexane 1 
9 Methanol 1 
10 Benzyl alcohol 1 
11 Ethanol 0.1 
12 1-butanol 0.4 
13 1-propanol 0.2 
14 2-butanol 0.4 
15 2-propanol 0.4 
16 1,4-butanediol 0.5 
 
The CGC for 4a ranges between 0.7% wt. in the case of 1-pentanol 
and 1.7% wt. in the case of methanol. The CGC values for 4d are 
relatively high (between 1.5 and 1.8%). In contrast, the CGCs for 4e 
proved to be very low, consistent with the additional hydrogen 
bonding functionality. In ethanol this gelator gives gels at a 
concentration of only 0.1% wt. (Figure 2) and hence may be 
regarded as a ‘supergelator’.32 The CGC values are generally found 
to be low in alcoholic solvents, perhaps reflecting a solvophobic 
effect from the highly lipophilic substituents coupled with strong 
self-association from the amide groups. Similar effects are noted for 
tris(amide) derivatives.33 
 
Figure 2. Gels for 4e in Ethanol at different concentrations (% wt). 
The gel to sol phase transition temperature, (Tsol) was assessed 
using the dropping ball method.34 Gels derived from 4a are stable, 
ARTICLE Journal Name 
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
(e.g. 1-pentanol Tsol 105oC at a concentration of 2% wt, Table 2, 
entry 1). As expected the gel stability decreases with concentration 
(Table 2, Entries 1-6). Compound 4d has a relatively low Tsol 
between 45 and 53 oC highlighting the relatively weak self-
association of the gelator molecules and the generally poor gelation 
properties of this compound (Table 2, entries 7-8). 
The outcomes shown in Table 2 indicate the highly effective gelator 
properties of compound 4e in particular, with Tsol values well above 
the solvent boiling point in many cases. Gels of 4e apparently do 
not follow the trend of decreasing gel stability with concentration, 
and as a consequence, the Tsol does not decrease with 
concentration. Surprisingly, the stability of these gels is the same at 
every concentration and every solvent in the range 0.5 – 2 % wt. 
The strong hydrogen bonds between the protons of N-H groups and 
interdigitation between the long alkyl chains may explain the 
strength of these gels and the high values of Tsol. 
 
Table 2. Critical gel-to-sol transition temperatures (Tsol) for 4a, 4d 
and 4e at different concentrations. 
Compound Entry Solvent Concentration 
(%wt) 
Tsol 
(oC) 
4a 
1 1-pentanol 2 105 
2 2-propanol 2 74 
3 Methanol 2 65 
4 1,4-
butanediol 
2 76 
5 1-pentanol 1 62 
6 1,4-
butanediol 
1 50 
4d 
7 DMF 2 45 
8 Diethylene 
glycol 
2 53 
4e 
9 Ethanol 2 167 
10 1-butanol 2 140 
11 1-propanol 2 162 
12 Methanol 2 175 
13 DMF 2 165 
14 Ethanol 1 154 
15 Hexane 1 128 
16 1-butanol 1 150 
17 1-propanol 1 151 
18 2-butanol 1 118 
19 2-propanol 1 121 
20 Methanol 1 178 
21 Benzyl 
alcohol 
1 164 
22 Ethanol 0.5 148 
23 1-butanol 0.5 164 
24 1-propanol 0.5 146 
25 2-butanol 0.5 136 
26 2-propanol 0.5 70 
27 1,4-
butanediol 
0.5 170 
 
The morphology of the supramolecular aggregates as dried xerogels 
was examined by SEM.35,36 As a general rule, small-molecule 
supramolecular gels exhibit an interconnected fibrous 
morphology.37 SEM images of xerogels from ethanol of 4e are 
shown in Figure 3a. In contrast, 4b xerogels showed a spheroidal 
morphology (Figure 3b), consistent with the lack of gelation by this 
compound.  
a) 
 
b) 
 
Figure 3. a) SEM images for compound 4e. b) SEM images for 
compound 4b. 
Oscillatory rheology measurements revealed the viscoelastic state 
of the gel materials.38,39 Frequency and stress sweep experiments, 
showed that for all gels the elastic modulus, G’, is at least an order 
of magnitude greater than the viscous modulus, G”, confirming the 
solid-like behaviour of the materials.  
Rheology experiments were used to compare gels at the same 
concentration (2% wt) in different solvents, and to compare the 
stability of different gels of the same solvent at different 
concentrations. The yield stresses () for each gel were determined 
showing the point where the gels broke down. As a general rule, 
high values of yield stress indicate a higher stability of the gel.40 
Gels of 4a and 4e proved to be particularly robust, for example 4a 
or 4e exhibit  more than 1000 Pa in both cases (Figure 4 c, S8 and 
S10). In contrast, 4d gives much weaker gels with yield stresses of 
around 20 and 40 Pa in DMF and diethylene glycol, respectively 
(Figure 4b and S9). While all of these compounds possess a 
trialkoxyaryl motif the additional amide groups in 4e apparently 
results in more robust fibre formation. In the case of 4a the gels are 
opaque suggesting larger, more crystalline particles and the high 
yield stress may represent the presence of large solid particles 
rather than an elastic gel network. This difference is also reflected 
in the higher  values for 4e compared to 4a in 1,4-butanediol 
(1585 vs 914 Pa)  
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a) 
 
 
 
 
   b)                     
 
 
 
 
     c)                               
 
 
 
 
Figure 4. Stress sweep experiments at a concentration of 2% wt. for 
a) 4a in 1,4-butanediol (= 914 Pa). b) 4d in DMF (= 20 Pa). c) 4e in 
1,4-butanediol (= 1585 Pa). 
We also compared the gels of 4e in ethanol, at various 
concentrations (2% wt, 1% wt. and 0.5 %wt) (Figure S11 in SI). 
Consistent with the Tsol measurements the stability of the gel 
decreases with concentration. In general, when the concentration is 
decreased, the number of inter-fibre interactions decrease due to 
the lower fibre density, resulting in weakening of the gel.          
Stimuli response 
Responsive gels are of significant current interest as advanced 
materials.41 Given the potential importance of the balance between 
hydrophobic and hydrogen bonding interactions in gels of the most 
effective gelator 4e the influence of pH on its gelation properties 
was examined. Gels in ethanol at 2% wt. of 4e were treated with a 
solution of 0.1 M NaOH (pH=13). This resulted in the transformation 
of the gel into a sol suggesting potential disruption of the hydrogen 
bonded network because of deprotonation or increased ionic 
strength. When the base-treated gel was acidified with a strong 
acid at the same concentration (0.1 M HCl, pH=1), the gel recovers 
its structure (Figure 5) suggesting reprotonation and lending weight 
to the important role of hydrogen bonding in this system. 
 
 
 
 
Figure 5. pH response of 4e. 
The influence of a range of metal ions on gel formation of 
compound 4e was examined by adding 0.2 M of different metal 
salts (Cu2+, Co2+ and Zn2+ as the sulfate salts and Na+ and Li+ as 
chlorides) to hot solutions of the gelator, followed by cooling. When 
treated with Cu2+, Co2+ and Zn2+ sulfates the gels did not form, 
however in the presence of Na+ and Li+ the gels remained stable 
(Figure 6). A possible explanation is the greater affinity of the 
transition metal ions for the gelator amide carbonyl oxygen atoms 
or triazole nitrogen atoms.  
 
Figure 6. Response of gels of 4e (2% wt. in Ethanol) to the addition 
of 0.2 M solutions of metal salts. 
Gel phase crystallization of pharmaceutical drugs 
One important potential application of low molecular weight 
organogels is as media for the crystallization of active 
pharmaceutical ingredients (APIs).11 Organogels of 4e were 
examined as potential crystallization media for pharmaceutical 
APIs. A range of representative APIs were chosen based on their 
known polymorphism and chemical diversity; namely theophylline, 
sulfathiazole, sulfamerazine and niflumic acid (Figure 7). 
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Figure 7. Structure of the different compounds used for 
crystallization within the gel. 
A series of crystallization experiments was performed to optimize 
the crystallization conditions. The optimized conditions for gelation 
are found to be 10 mg/mL drug concentration at 0.1% gelator 
concentration. A mixture of gelator and drugs in a particular solvent 
was warmed followed by sonication to give a gel of the API solution. 
Samples in open vials were then left undisturbed at room 
temperature over periods of several weeks to allow crystallization. 
In many cases, no crystallization was observed. The experiments 
were repeated three times with the same results in all cases. The 
vials were checked visually for crystallization and crystalline 
products analysed by X-ray powder and single crystal diffraction. No 
significant difference on crystallization outcome between gel and a 
solution phase control experiment under the same conditions, was 
observed for theophylline, sulfamerazine and niflumic acid. The 
experiments resulted in the known Form II in the case of 
theophylline in ethanol42, the Pna21 polymorph in the case of 
sulfamerazine43 and P21/n form in the case of niflumic acid. 
Microscopic images of theophylline and sulfathiazole crystals 
obtained through gel crystallization using 4e, shows a cluster of 
needle-shaped crystals slightly bigger in size than those obtained 
from solution crystallization. In the case of niflumic acid a change in 
crystal habit was observed inside the gels in methanol in 
comparison to the solution crystallization (Figure 8). In the gel 
phase crystallization block shaped crystals were observed, whereas 
from solution crystallization in methanol resulted in needle type 
crystals. In the gel phase crystallization of sulfathiazole a change 
from polymorphic Form II in solution to room temperature kinetic 
Form I44 was observed in the presence of the gel (Figure 9). 
Polymorphic form was confirmed by unit cell determination on 
representative crystals (Figure S12). This interesting outcome 
suggests that the 4e gelator either inhibits crystallization of Form II 
or increases the nucleation rate of Form I.  
 
 
 
 
Figure 8. Crystals of niflumic acid grown inside the gel  of 4e (top) in 
methanol and by solution evaporation (bottom). 
 
                 
 
Figure 9. Crystals of sulfathiazole grown in 1-propanol gels of 4e 
(top) and by solution evaporation (bottom). 
 
Conclusions 
Derivatives of 2H-benzo[d]1,2,3-triazole 4a, 4d, and 4e gave a 
number of organogels in specific solvents. Compound 4e in 
particular proved to be an effective gelator of a wide range of 
solvents even at low concentrations, in some cases acting as a 
supergelator (e.g. ethanol, critical gelation concentration 0.1 %wt). 
These gels also displayed high thermal stability and significant 
mechanical resistance. Gels of 4e were used in the crystallization of 
the pharmaceutical drugs theophylline, sulfathiazole, sulfamerazine 
and niflumic acid. In the case of sulfathiazole the gel induces a 
change in the polymorphic form observed in comparison to solution 
crystallization under the same conditions. These gels offer 
significant scope for expanding the rage of current polymorph 
discovery methods particularly in the pharmaceutical industry. 
Experimental  
General 
All reagents were used as purchased. Reactions with air-sensitive 
materials were carried out under an argon atmosphere. Flash 
chromatography was performed using silica gel (Merck, Kieselgel 
60, 230–240 mesh or Scharlau 60, 230–240 mesh). Analytical thin 
layer chromatography (TLC) was performed using aluminium-coated 
Merck Kieselgel 60 F254 plates. NMR spectra were recorded on a 
Varian Unity 500 (1H: 500 MHz; 13C: 125 MHz) spectrometer at 298 
K using deuterated solvents an internally referenced against the 
residual protic solvent signal. Chemical shifts () are denoted in 
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ppm. Multiplicities are denoted as follows: s = singlet, d = doublet, t 
= triplet, m = multiplet, br = broad.  
SEM images were obtained on a JEOL JSM 6335F microscope 
working at 10 kV. The samples for SEM imaging were prepared by a 
controlled precipitation using the appropriate solvent or by slow 
diffusion by using mixtures of solvents, depending on their solubility 
properties (see the corresponding figure caption for a detailed 
description). The corresponding solid was deposited onto a glass 
substrate and the remaining solvent was slowly evaporated. 
IR spectra were recorded on a IR Shimadzu, FTIR IR Affinity 1S WL 
C/Lab solution, with a zinc selenide crystal and ATR device.  
For drop-milling test to calculate Tsols a small metal ball with a 
diameter of 1 cm was used for the experiments. 
Rheological measurements were performed with advanced 
rheometer AR 2000 from TA Instruments which was equipped with 
a cooling system (Julabo C). A 20 mm plain plate geometry (stainless 
steel) was used. First strain sweep measurements were carried out 
to estimate the strain in % at which reasonable torque values were 
given (about 10 times of the transducer resolution limit). 
Afterwards, frequency sweep measurements and time sweep 
measurements from 0.1 to 4000 Pa were performed.  
Gel phase crystallizations were performed by adding 10 mg of the 
drug in a vial containing 0.1% wt. of the gelator in a particular 
solvent. The vials were warmed followed by sonication to obtain a 
gel of the API solution. Crystals start appearing 2-3 days as observed 
by microscopy. Crystals were characterized by determining the unit 
cell parameter. 
General synthetic procedure for derivatives 4 
A mixture of 2-(3,5-bis(trifluoromethyl)phenyl)-4,7-dibromo-2H-
benzo[d][1,2,3]triazole (2) (0.100 g, 0.200 mmol), the corresponding 
acetylene derivative (3) (0.4 mmol), DBU (0.061 g, 0.400 mmol), CuI 
(0.002 g, 0.010 mmol) and Pd-EncatTM TPP30 (0.018 g, 0.007 
mmol) was charged under argon to a dried microwave vessel. 
CH3CN (1 mL) was added. The vessel was closed and irradiated at 
130 °C for 20 min. The crude reaction product was purified by 
chromatography, eluting with hexane/ethyl acetate to give 
analytically pure products 4. 
2-(3,5-bis(trifluoromethyl)phenyl)-4,7-bis((3,4,5-
tris(dodecyloxy)phenyl)ethynyl)-2H-benzo[d][1,2,3]triazole (4a): 
From 1,2,3-tris(dodecyloxy)-5-ethynylbenzene (3a) (0.266 g, 0.400 
mmol), derivative 4a (0.201 g, 61%) was obtained as an orange solid 
by chromatography eluting with hexane/ethyl acetate (98/2). P.f: 
156-158ºC.1H-NMR (CDCl3, ppm): 9.01 (s, 2H, o-N-Ph), 7.96 (s, 1H, 
p-N-Ph), 7.63 (s, 2H, Hbenzotriazole), 6.91 (s, 4H, o-Ph), 4.01 (t, 12H, -
OCH2), 1.61-1.21 (m, 120 H, -CH2), 0.93 (s, 18H, -CH3).13C-NMR 
(CDCl3, ppm): 147.0, 141.2, 139.5, 138.3, 131.9, 131.3, 124.7, 123.6, 
123.1, 122.0, 115.5, 102.2, 93.3, 92.8, 31.9, 29.6, 29.3, 25.9, 22.7, 
14.0. HRMS calculated for (C102H159F6N306) M+ 1636.21 found 
1636.78. Elemental analysis: C, 74.80; H, 9.89; F, 6.96; N, 2.58; O, 
5.88. 
4,4'-((2-(3,5-bis(trifluoromethyl)phenyl)-2H-benzo[d][1,2,3]triazole-
4,7-diyl)bis(ethyne-2,1-diyl))dibenzonitrile (4b): From 4-
ethynylbenzonitrile (3b) (0.051 g, 0.400 mmol), derivative 4b (0.077 
g, 66 %) was obtained as an orange solid by chromatography eluting 
with hexane/ethyl acetate (9/1). P.f: 198-200ºC. 1H-NMR (CDCl3, 
ppm): 8,98 (s, 2H, o-N-Ph), 8.03 (s, 1H, p-N-Ph), 7.81-7.79 (d, 4H, o-
Ph), 7.74-7.72 (d, 4H, m-Ph), 7.57 (s, 2H,  Hbenzotriazole) 13C-NMR 
(CDCl3, ppm): 141.5, 139.3, 133.0, 131.8, 131.3, 127.1, 124.4, 123.6, 
123.1, 122.0, 118.6, 115.4, 112.3, 93.3, 92.7. HRMS calculated for 
(C32H13F6N5) M+ 581.11 found 581.37. Elemental analysis: C, 66.11; 
H, 2.25; F, 19.61; N, 12.05. 
4,4'-((2-(3,5-bis(trifluoromethyl)phenyl)-2H-benzo[d][1,2,3]triazole-
4,7-diyl)bis(ethyne-2,1-diyl))bis(N-dodecylbenzamide) (4c) From N-
dodecyl-4-ethynylbenzamide (3c) (0.127 g, 0.400 mmol), derivative 
4c (0.128 g, 66%) was obtained as a brown solid by chromatography 
eluting with hexane/ethyl acetate (4/1). P.f: 166-168ºC. 1H-NMR 
(CDCl3, ppm): 8.99 (s, 2H, o-N-Ph), 8.01 (s, 1H, p-N-Ph), 7.70 (s, 2H, 
NH), 7.65-7.63 (d, 4H, m-Ph), 7.58 (s, 2H, Hbenzotriazole), 7.54-7.52 (d, 
4H, o-Ph), 3.85-3.83 (t, 4H, -NCH2), 1.41-1.25 (m, 40H, -CH2), 0.91 (s, 
6H, -CH3). 13C-NMR (CDCl3, ppm): 158.5, 141.2, 139.4, 133.0, 132.4, 
131.9, 131.3, 127.1, 126.1, 124.4, 123.6, 123.1, 122.0, 93.3, 92.7, 
39.7, 30.0, 29.6, 29.3, 26.7, 22.7, 14.1. HRMS calculated for 
(C56H65F6N502) M+ 953.50 found 953.84. Elemental analysis: C, 
70.50; H, 6.87; F, 11.95; N, 7.34; O, 3.35. 
N,N'-(((2-(3,5-bis(trifluoromethyl)phenyl)-2H-
benzo[d][1,2,3]triazole-4,7-diyl)bis(ethyne-2,1-diyl))bis(4,1-
phenylene))bis(3,4,5-tris(dodecyloxy)benzamide) (4d): From 3,4,5-
tris(dodecyloxy)-N-(4-ethynylphenyl)benzamide (3d) (0.142 g, 0.400 
mmol), derivative 4d (0.119 g, 69%) was obtained as a deep orange 
solid by chromatography eluting with hexane/ethyl acetate (9/1). 
P.f: . 1H-NMR (CDCl3, ppm): 8.98 (s, 2H, o-N-Ph), 8.03 (s, 1H, p-N-
Ph), 7.72 (s, 2H, NH), 7.64-7.62 (d, 4H, m-Ph), 7.58 (s, 2H, H, 
Hbenzotriazole), 7.54-7.51 (d, 4H, o-Ph), 7.06 (s, 4H, o-PhOC12H25), 4.03-
4.01 (t, 12H, -OCH2), 1.41-1.25 (m, 120 H, -CH2), 0.91 (s, 18H, -CH3). 
13C-NMR (CDCl3, ppm): 153.1, 152.9, 144.9, 133.1, 131.4, 127.2, 
123.4, 121.8, 121.7, 121.5, 119.6, 119.5, 110.9, 107.8, 106.9, 74.1, 
69.5, 31.9, 30.3, 29.8, 29.7, 29.6, 29.4, 29.3, 26.1, 22.7, 14.2. HRMS 
calculated for (C116H169F6N508) M+ 1874.29 found 1874.66. 
Elemental analysis: C, 74.29; H, 9.07; F, 6.08; N, 3.73; O, 6.82. 
N,N'-(((4,4'-((2-(3,5-bis(trifluoromethyl)phenyl)-2H-
benzo[d][1,2,3]triazole-4,7-diyl)bis(ethyne-2,1-
diyl))bis(benzoyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(3,4,5-
tris(dodecyloxy)benzamide) (4e): From 3,4,5-tris(dodecyloxy)-N-(2-
(4-methylbenzamido)ethyl)benzamide (3e) (0.337 g, 0.40 mmol), 
derivative 4e (0.213 g, 51%) was obtained as a brown solid by 
chromatography eluting with ethyl acetate. P.f: 300-302ºC. 1H-NMR 
(CDCl3, ppm): 9.91 (s, 2H, HamidePhBzt), 9.61 (s, 2H, HamidePhOC12H25), 
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9.01 (s, 2H, o-N-Ph), 8.01 (s, 1H, p-N-Ph), 7.66-7.64 (d, 4H, m-Ph), 
7.60 (s, 2H, Hbenzotriazole), 7.54-7.51 (d, 4H, o-Ph), 7.06 (s, 4H, o-
PhOC12H25), 4.03-4.01 (t, 12H, -OCH2), 3.61 (s, 8H, N-CH2-CH2-N), 
1.41-1.25 (m, 120H, -CH2), 0.92 (s, 18H, -CH3).  13C-NMR (CDCl3, 
ppm): 164.7, 159.8, 153.7, 142.0, 141.2, 139.4, 137.7, 132.0, 130.9, 
124.4, 124.1, 123.6, 123.1, 122.6, 122.0, 121.4, 118.3, 105.6, 93.3, 
92.7, 69.0, 39.6, 31.9, 29.6, 29.3, 26.0, 22.7, 14.1. HRMS calculated 
for (C122H179F6N7010) M+ 2016.36 found 2016.74. Elemental analysis: 
C, 72.62; H, 8.94; F, 5.65; N, 4.86; 7.93. 
Alkynyl derivatives 3 
1,2,3-tris(dodecyloxy)-5-ethynylbenzene (3a): A brown solid (3.89 g, 
72%) was obtained and identified as 3a. 1H-RMN (CDCl3, 500 MHz): 
6.69 (s, 2H, o-H), 3.93-3.96 (m, 6H, 3xO-CH2), 2.98 (s, 1H, ≡CH), 
1.71-1.80 (m, 6H, 3xCH2), 1.44-1.47 (m, 6H, 3xCH2), 1.26-1.34 (m, 
48H, -CH2), 0.87-0.89 (m, 9H, 3xCH3) ppm. 13C-RMN (CDCl3, 125 
MHz): 14.1, 22.7, 26.1, 26.2, 29.3, 29.3, 29.4, 29.5, 29.6, 29.7, 29.8, 
29.9, 30.0, 30.3, 31.8, 31.9, 69.1, 73.5, 75.7, 84.0, 110.7, 116.4, 
139.6, 152.9 ppm. HRMS calculated for (C44H7803) M+ 654.60 found 
654.74. 
 
N-dodecyl-4-ethynylbenzamide (3c): A black solid (0.960 g, 97%) 
was obtained and identified as 3c. 1H-NMR (CDCl3, ppm): 7.80 (s, 
1H, NH), 7.65-7.63 (d, 2H, m-Ph), 7.54-7.52 (d, 2H, o-Ph), 3.85-3.83 
(t, 12H, -OCH2), 3.04 (s, 1H, ≡CH), 1.41-1.25 (m, 120 H, -CH2), 0.91 (s, 
18H, -CH3). 158.5, 133.0, 132.5, 127.2, 126.1, 93.4, 92.8, 39.7, 30.0, 
29.6, 29.3, 26.7, 22.7, 14.2. HRMS calculated for (C21H31NO) M+ 
313.24 found 313.47. 
3,4,5-tris(dodecyloxy)-N-(4-ethynylphenyl)benzamide (3d): A white 
solid (0.800 g, 48%) was obtained and identified as 3d. 1H-NMR 
(CDCl3, ppm): 7.76 (s, 1H, NH), 7.63-7.61 (d, 2H, m-Ph), 7.54-7.51 (d, 
4H, o-Ph), 7.04 (s, 2H, o-PhOC12H25), 4.04-4.02 (t, 12H, -OCH2), 2.92 
(s, 1H, ≡CH) 1.41-1.25 (m, 120 H, -CH2), 0.91 (s, 18H, -CH3). 13C-NMR 
(CDCl3, ppm): 153.1, 152.9, 144.9, 133.1, 131.4, 127.2, 126.2, 123.4, 
74.1, 69.5, 31.9, 30.3, 29.8, 29.7, 29.6, 29.4, 29.3, 26.1, 22.7, 14.2. 
HRMS calculated for (C51H83NO4) M+ 773.63 found 773.99.  
3,4,5-tris(dodecyloxy)-N-(2-(4-ethynylbenzamido)ethyl)benzamide 
(3e): A pale yellow solid (0.090 g, 92%) was obtained and identified 
as 3e. 1H-NMR (CDCl3, ppm): 9.91 (s, 1H, HamidePhBzt), 9.61 (s, 1H, 
HamidePhOC12H25), 7.66-7.64 (d, 2H, m-Ph), 7.54-7.51 (d, 2H, o-Ph), 7.06 
(s, 2H, o-PhOC12H25), 4.03-4.01 (t, 12H, -OCH2), 3.61 (s, 8H, N-CH2-
CH2-N), 3.06 (s, 1H, ≡CH),  1.41-1.25 (m, 120H, -CH2), 0.92 (s, 18H, -
CH3).  13C-NMR (CDCl3, ppm): 164.7, 159.8, 153.7, 142.0, 141.2, 
139.4, 137.8, 132.1, 130.9, 124.6, 93.2, 92.6, 69.0, 39.6, 31.9, 29.6, 
29.3, 26.0, 22.7, 14.1. HRMS calculated for (C54H88N2O5) M+ 844.13 
found 843.79.  
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